• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX-XRX43002A
Device Problem Coagulation in Device or Device Ingredient (1096)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/13/2018
Event Type  malfunction  
Manufacturer Narrative
Weight - (b)(6) kilograms.Implanted date: device was not implanted.Explanted date: device was not explanted.510(k): k130520.The actual device was discarded by the involved user facility and was not returned for evaluation, however, a photograph was provided for evaluation.A review of the photos noted the presence of thrombus adhering to the filter with the surface of blood inside the reservoir being lowered.The reported phenomenon of the thrombus melting like ice was not confirmed in the photos.The complaint file was searched back to the past two years for reports of the phenomenon of thrombus melting like ice.There has been no other report of this nature to date.A review of the device history record of the involved product code/lot number combination revealed no findings.There is no evidence that this event was related to a device defect or malfunction.Based on the investigation, it is likely that the blood in which some coagulation factors had been activated flowed into the reservoir of the actual sample, resulting in the reported thrombus formation.The cause of the reported phenomenon of the thrombus melting like ice cannot be identified.However, the exact cause of the reported event cannot be definitively determined.The ifu states: "adequate heparinization of the blood is required to prevent it from clotting in the system." (b)(4).
 
Event Description
The user facility reported that red thrombus formed on the filter inside the reservoir of the capiox device immediately before the termination of the circulation.After the procedure, during blood collection, the red thrombus adhering on the filter melted like ice and disappeared.The product was not changed out.There was no blood loss.There was no harm to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
mark vornheder
reg. no. 2243441
950 elkton blvd
elkton, MD 21921
8002837866
MDR Report Key7974624
MDR Text Key124002753
Report Number9681834-2018-00191
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/17/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2019
Device Catalogue NumberCX-XRX43002A
Device Lot Number180420
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/21/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/20/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age74 YR
Patient Weight63
-
-